Laboratorios Farmaceuticos Rovi, S.A.
BME: ROVI.MC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Madrid Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Juan Lopez-Belmonte Encina
- Employees
- 2,197
- Headquarters
- Madrid, Spain
- IPO year
- 2007
- Market cap
- €3.2B
- Website
- https://www.rovi.es
Loading ROVI…
Loading profile data…Frequently asked questions about ROVI
What does Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) do?
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to preven...
Where does ROVI.MC trade?
Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) trades on the Madrid Stock Exchange.
What sector is ROVI.MC in?
Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Laboratorios Farmaceuticos Rovi, S.A.?
Juan Lopez-Belmonte Encina is the chief executive officer of Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC).
Where is Laboratorios Farmaceuticos Rovi, S.A. headquartered?
Laboratorios Farmaceuticos Rovi, S.A. is headquartered in Spain.
Does ROVI.MC pay a dividend?
Yes — Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) paid a trailing twelve-month dividend of EUR 0.94 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ROVI.MC go public?
Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) completed its initial public offering in 2007.